Literature DB >> 23016918

Rezymogenation of active urokinase induced by an inhibitory antibody.

Longguang Jiang1, Kenneth A Botkjaer, Lisbeth M Andersen, Cai Yuan, Peter A Andreasen, Mingdong Huang.   

Abstract

An important regulatory mechanism of serine proteases is the proteolytic conversion of the inactive pro-enzyme, or zymogen, into the active enzyme. This activation process is generally considered an irreversible process. In the present study, we demonstrate that an active enzyme can be converted back into its zymogen form. We determined the crystal structure of uPA (urokinase-type plasminogen activator) in complex with an inhibitory antibody, revealing that the antibody 'rezymogenizes' already activated uPA. The present study demonstrates a new regulatory mechanism of protease activity, which is also an extreme case of protein allostery. Mechanistically, the antibody binds a single surface-exposed loop, named the autolysis loop, thereby preventing the stabilization of uPA in its active conformation. We argue that this autolysis loop is a key structural element for rezymogenation of other proteases, and will be a new target site for pharmacological intervention with serine protease activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23016918     DOI: 10.1042/BJ20121132

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  9 in total

1.  6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer.

Authors:  Benjamin J Buckley; Ashraf Aboelela; Elahe Minaei; Longguang X Jiang; Zhihong Xu; Umar Ali; Karen Fildes; Chen-Yi Cheung; Simon M Cook; Darren C Johnson; Daniel A Bachovchin; Gregory M Cook; Minoti Apte; Mingdong Huang; Marie Ranson; Michael J Kelso
Journal:  J Med Chem       Date:  2018-09-07       Impact factor: 7.446

2.  Non-canonical proteolytic activation of human prothrombin by subtilisin from Bacillus subtilis may shift the procoagulant-anticoagulant equilibrium toward thrombosis.

Authors:  Giulia Pontarollo; Laura Acquasaliente; Daniele Peterle; Roberta Frasson; Ilaria Artusi; Vincenzo De Filippis
Journal:  J Biol Chem       Date:  2017-07-06       Impact factor: 5.157

3.  Halogen bonding for the design of inhibitors by targeting the S1 pocket of serine proteases.

Authors:  Longguang Jiang; Xu Zhang; Yang Zhou; Yayu Chen; Zhipu Luo; Jinyu Li; Cai Yuan; Mingdong Huang
Journal:  RSC Adv       Date:  2018-08-06       Impact factor: 4.036

4.  Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator.

Authors:  Tobias Kromann-Hansen; Eva Louise Lange; Hans Peter Sørensen; Gholamreza Hassanzadeh-Ghassabeh; Mingdong Huang; Jan K Jensen; Serge Muyldermans; Paul J Declerck; Elizabeth A Komives; Peter A Andreasen
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

5.  Ligand binding modulates the structural dynamics and activity of urokinase-type plasminogen activator: A possible mechanism of plasminogen activation.

Authors:  Tobias Kromann-Hansen; Eva Louise Lange; Ida K Lund; Gunilla Høyer-Hansen; Peter A Andreasen; Elizabeth A Komives
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

6.  Crystal structure, epitope, and functional impact of an antibody against a superactive FVIIa provide insights into allosteric mechanism.

Authors:  Longguang Jiang; Xie Xie; Jinyu Li; Egon Persson; Mingdong Huang
Journal:  Res Pract Thromb Haemost       Date:  2019-06-20

7.  Allosteric inhibition of HTRA1 activity by a conformational lock mechanism to treat age-related macular degeneration.

Authors:  Stefan Gerhardy; Mark Ultsch; Wanjian Tang; Evan Green; Jeffrey K Holden; Wei Li; Alberto Estevez; Chris Arthur; Irene Tom; Alexis Rohou; Daniel Kirchhofer
Journal:  Nat Commun       Date:  2022-09-05       Impact factor: 17.694

8.  Structure of an affinity-matured inhibitory recombinant fab against urokinase plasminogen activator reveals basis of potency and specificity.

Authors:  N Sevillano; M F Bohn; M Zimanyi; Y Chen; C Petzold; S Gupta; C Y Ralston; C S Craik
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-11-19       Impact factor: 3.036

9.  Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat.

Authors:  Gaohui Sun; Yaqun Sui; Yang Zhou; Junlin Ya; Cai Yuan; Longguang Jiang; Mingdong Huang
Journal:  J Virol       Date:  2021-06-23       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.